A PHASE 3 RANDOMIZED WITHDRAWAL AND DOSE-UP TITRATION, MULTI- CENTER EXTENSION STUDY INVESTIGATING THE SAFETY, EFFICACY, AND TOLERABILITY OF RITLECITINIB IN ADULT AND ADOLESCENT PARTICIPANTS WITH NONSEGMENTAL VITILIGO

Project: Research

Project Details

StatusActive
Effective start/end date23/07/24 → 23/07/26

Keywords

  • clinical trial
  • vitiligo
  • Ritlecitinib